UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 2)*
Nurix Therapeutics, Inc.
(Name of Issuer)
COMMON STOCK, $0.001 PAR VALUE PER SHARE
(Title of Class of Securities)
67080M103
(CUSIP Number)
December 31, 2022
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
☐ | Rule 13d-1(b) |
☐ | Rule 13d-1(c) |
☒ | Rule 13d-1(d) |
* | The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. |
The information required in the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 67080M103 | SCHEDULE 13G | Page 2 of 9 Pages |
1. |
NAMES OF REPORTING PERSONS
Third Rock Ventures III, L.P. | |||||
2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐ (b) ☒ | |||||
3. | SEC USE ONLY
| |||||
4. | CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5. | SOLE VOTING POWER
0 | ||||
6. | SHARED VOTING POWER
0 | |||||
7. | SOLE DISPOSITIVE POWER
0 | |||||
8. | SHARED DISPOSITIVE POWER
0 |
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0 | |||||
10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0% (1) | |||||
12. | TYPE OF REPORTING PERSON
PN |
(1) | The percent of class was calculated based on 47,147,781 shares of common stock issued and outstanding as of September 30, 2022, as disclosed in the Issuers 10-Q filed with the Securities and Exchange Commission on October 6, 2022. |
CUSIP No. 67080M103 | SCHEDULE 13G | Page 3 of 9 Pages |
1. |
NAMES OF REPORTING PERSONS
Third Rock Ventures GP III, L.P. | |||||
2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐ (b) ☒ | |||||
3. | SEC USE ONLY
| |||||
4. | CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5. | SOLE VOTING POWER
0 | ||||
6. | SHARED VOTING POWER
0 | |||||
7. | SOLE DISPOSITIVE POWER
0 | |||||
8. | SHARED DISPOSITIVE POWER
0 |
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0 | |||||
10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0% (1) | |||||
12. | TYPE OF REPORTING PERSON
PN |
CUSIP No. 67080M103 | SCHEDULE 13G | Page 4 of 9 Pages |
1. |
NAMES OF REPORTING PERSONS
TRV GP III, LLC | |||||
2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐ (b) ☒ | |||||
3. | SEC USE ONLY
| |||||
4. | CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5. | SOLE VOTING POWER
0 | ||||
6. | SHARED VOTING POWER
0 | |||||
7. | SOLE DISPOSITIVE POWER
0 | |||||
8. | SHARED DISPOSITIVE POWER
0 |
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0 | |||||
10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0% (1) | |||||
12. | TYPE OF REPORTING PERSON
OO |
CUSIP No. 67080M103 | SCHEDULE 13G | Page 5 of 9 Pages |
1. |
NAMES OF REPORTING PERSONS
Robert I. Tepper | |||||
2. | CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a) ☐ (b) ☒ | |||||
3. | SEC USE ONLY
| |||||
4. | CITIZENSHIP OR PLACE OF ORGANIZATION
United States |
NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH |
5. | SOLE VOTING POWER
184,544 | ||||
6. | SHARED VOTING POWER
0 | |||||
7. | SOLE DISPOSITIVE POWER
184,544 | |||||
8. | SHARED DISPOSITIVE POWER
0 |
9. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
184,544 | |||||
10. | CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
☐ | |||||
11. | PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
0.4% | |||||
12. | TYPE OF REPORTING PERSON
IN |
CUSIP No. 67080M103 | SCHEDULE 13G | Page 6 of 9 Pages |
Item 1. | Issuer |
(a) | Name of Issuer: |
Nurix Therapeutics, Inc. (the Issuer)
(b) | Address of Issuers Principal Executive Offices: |
1700 Owens Street, Suite 205
San Francisco, CA 94158
Item 2. | Filing Person |
(a) (c) Name of Persons Filing; Address; Citizenship:
(i) | Third Rock Ventures III, L.P. (TRV III); |
(ii) | Third Rock Ventures GP III, L.P. (TRV GP III), which is the sole general partner of TRV III; |
(iii) | TRV GP III, LLC (TRV GP III LLC), which is the sole general partner of TRV GP III; and |
(vi) | Robert I. Tepper (Tepper, and collectively with TRV III, TRV GP III and TRV GP III, the Reporting Persons), the managing member of TRV GP III LLC. |
The address of the principal business office of each of the Reporting Persons is Third Rock Ventures, LLC, 201 Brookline Ave, Suite 1401, Boston, MA 02215.
Each of TRV III and TRV GP III is a Delaware limited partnership. TRV GP III LLC is a Delaware limited liability company. Tepper is a United States citizen.
(d) | Title of Class of Securities: |
Common stock, $0.001 par value per share, (the Common Stock)
(e) | CUSIP Number: |
67080M103
CUSIP No. 67080M103 | SCHEDULE 13G | Page 7 of 9 Pages |
Item 3. | If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: |
(a) |
☐ | Broker or dealer registered under Section 15 of the Act; | ||
(b) |
☐ | Bank as defined in Section 3(a)(6) of the Act; | ||
(c) |
☐ | Insurance company as defined in Section 3(a)(19) of the Act; | ||
(d) |
☐ | Investment company registered under Section 8 of the Investment Company Act of 1940; | ||
(e) |
☐ | An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); | ||
(f) |
☐ | An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); | ||
(g) |
☐ | A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); | ||
(h) |
☐ | A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); | ||
(i) |
☐ | A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; | ||
(j) |
☐ | A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); | ||
(k) |
☐ | Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: |
If filing as a non-U.S. institution in accordance with §240.13d-1(b)(1)(ii)(J), please specify the type of institution:
Item 4. | Ownership. |
(a) | and (b) Amount beneficially owned: |
(i) | TRV III directly owns 0 shares of Common Stock (the Shares), which represents approximately 0% of the outstanding shares of Common Stock. |
(ii) | TRV GP III is the general partner of TRV III and may be deemed to beneficially own the Shares. |
(iii) | TRV GP III LLC is the general partner of TRV GP III and may be deemed to beneficially own the Shares. |
(v) | As a managing member of TRV GP III LLC, Tepper may be deemed to beneficially own the Shares. Additionally, Tepper directly owns 44,878 shares of Common Stock and owns 139,666 shares of Common Stock through a trust. |
(c) | Number of shares as to which such person has: |
Number of Shares of Common Stock | ||||||||||||||||
Reporting Person | (i) | (ii) | (iii) | (iv) | ||||||||||||
TRV III |
0 | 0 | 0 | 0 | ||||||||||||
TRV GP III |
0 | 0 | 0 | 0 | ||||||||||||
TRV GP III LLC |
0 | 0 | 0 | 0 | ||||||||||||
Tepper |
184,544 | 0 | 184,544 | 0 |
(i) | Sole power to vote or direct the vote |
(ii) | Shared power to vote or to direct the vote |
(iii) | Sole power to dispose or to direct the disposition of |
(iv) | Shared power to dispose or to direct the disposition of |
The percent of class was calculated based on 47,147,781 shares of common stock issued and outstanding as of September 30, 2022, as disclosed in the Issuers 10-Q filed with the Securities and Exchange Commission on October 6, 2022.
CUSIP No. 67080M103 | SCHEDULE 13G | Page 8 of 9 Pages |
Item 5. | Ownership of Five Percent or Less of a Class. |
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☒.
Item 6. | Ownership of More than Five Percent on Behalf of Another Person. |
Not applicable.
Item 7. | Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. |
Not applicable.
Item 8. | Identification and Classification of Members of the Group. |
Not applicable.
Item 9. | Notice of Dissolution of Group. |
Not applicable.
Item 10. | Certification. |
Not applicable.
CUSIP No. 67080M103 | SCHEDULE 13G | Page 9 of 9 Pages |
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Date: February 14, 2023
THIRD ROCK VENTURES III, L.P. | ||
By: THIRD ROCK VENTURES GP III, L.P., | ||
General Partner | ||
By: TRV GP III, LLC, | ||
General Partner | ||
By: | /s/ Kevin Gillis | |
Kevin Gillis | ||
Chief Operating Officer | ||
THIRD ROCK VENTURES GP III, L.P. | ||
By: TRV GP III, LLC, | ||
General Partner | ||
By: | /s/ Kevin Gillis | |
Kevin Gillis | ||
Chief Operating Officer | ||
TRV GP III, LLC | ||
By: | /s/ Kevin Gillis | |
Kevin Gillis | ||
Chief Operating Officer | ||
ROBERT I. TEPPER | ||
/s/ Kevin Gillis, As attorney-in-fact | ||
Robert I. Tepper |